ScholarIQanswers from OpenAlex

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21

PaperCitations, authors & open-access status

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 have?

ScholarIQcitation count

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 has 185 citations in the OpenAlex counts ScholarIQ stores.

When was Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 published?

ScholarIQyear

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 has 2006 year in the ScholarIQ index.

What is the open-access status of Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21?

ScholarIQoa status

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 has closed oa status in the ScholarIQ index.

What is the DOI of Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21?

ScholarIQdoi

The DOI for Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 is on the source record.

What is the PMID of Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21?

ScholarIQpmid

The PMID for Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 is on the source record.

What is the OpenAlex record for Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21?

ScholarIQopenalex

The OpenAlex for Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial